Aikaterini Kanavaki

Dr. Aikaterini Kanavaki


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AKAikaterini Kanavaki
Aikaterini Kanavaki
KSKonstantinos Spengos
Konstantinos Spengos
MMMaria Moraki
Maria Moraki
PDPOLYXENI DELAPORTA
POLYXENI DELAPORTA
CKCatherine Kariyannis
Catherine Kariyannis
Antonis KattamisAntonis Kattamis
Antonis Kattamis
Patients with non-transfusion-dependent thalassemia (NTDT) are at risk of developing brain ischemia. Transcranial Doppler (TCD) has been established as a useful screening tool of cerebrovascular disease in patients with sickle cell disease. Proteins neuron specific enolase (NSE) and S100B are biomarkers that reflect CNS injury. The purpose of this study is to evaluate cerebral vessel vasculopathy and brain damage in NTDT patients using non-invasive methods as TCD and measurement serum levels of NSE and S100B. We included in our study 30 patients with NTDT, aged between 8 and 62 years old (mean: 29.4, median: 32) who presented in our Unit for regular follow-up. We performed in all patients a non-imaging TCD examination and have measured serum S100, NSE and lactate dehydrogenase (LDH) levels. We investigated the possible correlation between TCD results and S100B, NSE and LDH levels as well as between NSE-LDH and S100B-LDH levels by regression analysis. We found a statistically significant relationship for both NSE, S100B with LDH. We also found a statistically significant relationship for S100B and time-averaged mean velocity (TAMV)/peak velocity of left middle cerebral artery (MCA), NSE and pulsatility index (PI)/resistive index (RI) of the left posterior cerebral artery (PCA). TCD results correlated with biomarkers for brain ischemia. This finding enhances the role of TCD as a screening tool for brain ischemia in patients with NTDT.

19 April 2016 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
AOAlexandra Oeconomopoulou
Alexandra Oeconomopoulou
YVYvelise De Verney
Yvelise De Verney
AKAikaterini Kanavaki
Aikaterini Kanavaki
KSKalliopi Stefanaki
Kalliopi Stefanaki
KPKitty Pavlakis
Kitty Pavlakis
CSChristos Salakos
Christos Salakos
Inflammatory myofibroblastic tumor is a rare tumor of a borderline malignancy. Although it is commonly seen in children, the number of childhood cases in the current literature is limited. The lung is the most commonly affected location. However, cases that have been documented in the mesentery-omentum have mostly been located in the mesentery of the small bowel and not in the antimesenteric edge as in our patient. A 6-year-old Greek boy was referred to our hospital with acute abdominal pain mimicking appendicitis. Ultrasound and computed tomography revealed a solid mass in the abdomen. The patient underwent laparoscopic resection of the tumor, and histopathology and immunohistochemical analysis favored an omental-mesenteric myxoid hamartoma, which is a variant of an inflammatory myofibroblastic tumor. The patient’s postoperative course was uneventful, and he has been asymptomatic during follow-up. Inflammatory myofibroblastic tumor of the small intestine is a rare, benign neoplasm in children that should be considered as a possible cause of acute abdomen. A precise diagnosis can be made on the basis of histologic findings. Surgical excision is the treatment of choice.

7 July 2016
Verified
Journal Article
Closed access
AKAikaterini Kanavaki
Aikaterini Kanavaki
CDChristophe Draenert
Christophe Draenert
DCDimitri Ceroni
Dimitri Ceroni
SHSylviane Hanquinet
Sylviane Hanquinet

9 December 2025 in Pediatric Radiology
Verified
Journal Article
Closed access
PDF file
GPGiulia Perucca
Giulia Perucca
CSCarmelo Sofia
Carmelo Sofia
MDMaria Beatrice Damasio
Maria Beatrice Damasio
SFStéphanie Franchi-Abella
Stéphanie Franchi-Abella
AKAikaterini Kanavaki
Aikaterini Kanavaki
PPPhilippe Petit
Philippe Petit

12 February 2025 in Children
Verified
Journal Article
Open access
PDF file
AKAIKATERINI KYRIAKOPOULOU
AIKATERINI KYRIAKOPOULOU
KSKyriakos Samikos
Kyriakos Samikos
AKAikaterini Kanavaki
Aikaterini Kanavaki
EAEfthymia Alexopoulou
Efthymia Alexopoulou
MAMaria Argyropoulou
Maria Argyropoulou
VPVassiliki Papaevangelou
Vassiliki Papaevangelou
Objective: To investigate the clinical characteristics associated with the presence of LSV at birth. Design: Prospective 1:1 case–control study. Setting: Two tertiary neonatal units in Athens, Greece. Patients: Premature neonates (≤36 weeks gestational age) who underwent cerebral ultrasound within the first 3 weeks of life, where LSV was detected. Main outcome measure: Associations between LSV and clinical characteristics at birth. Both unmatched and matched analyses stratifying the study population by gestational week were conducted. Two-sided p-values were computed using the likelihood ratio test. Results: This study included 166 participants (83 cases and 83 controls). Neonates with LSV exhibited more concurrent cerebral findings, notably periventricular echogenicity. LSV was correlated with higher z-scores for head circumference and body length. LSV was not associated with congenital CMV. Conclusions: This study indicated a relationship between LSV and increased head circumference and body length. Further research is warranted to explore LSV’s pathophysiological mechanisms.